Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sanofi seeks approval for lixisenatide in Japan

June 11, 2012

Cinacalcet trial does not meet primary endpoint

June 11, 2012

Clinical trials reveal efficacy of albiglutide in treating diabetes

June 11, 2012

Clinical and preclinical results on tofogliflozin presented at ADA meeting

June 11, 2012

Beta Pharma synthesizes new glucokinase activators

June 11, 2012

Scientists at Callidus Biopharma patent new proteins for lysosomal storage disorders

June 11, 2012

FDA extends regulatory review period for ultralong-acting insulins

June 8, 2012

Alnylam completes enrollment in phase I ALN-TTR02 study and begins phase II trial

June 8, 2012

Novel mineralocorticoid receptor antagonists presented

June 8, 2012

Verva reports on proof-of-concept trial of repurposed drug

June 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...